ADIPOR1 Antibody

What is ADIPOR1 and why is it significant in research?

ADIPOR1 (Adiponectin Receptor 1) is a membrane protein that serves as a receptor for adiponectin. Despite initial characterization as a metabolic regulator, recent research has revealed its critical importance in vision biology. ADIPOR1 is highly enriched in the eye and brain, with particularly strong expression in photoreceptors and retinal pigment epithelium (RPE) . Its importance is underscored by the identification of human ADIPOR1 mutations that cause blindness, and knockout studies demonstrating its essential role in retinal function . While traditionally associated with glucose metabolism, the protein expression pattern suggests a more prominent role in neuronal tissues, making it an important target for vision research and neuroscience investigations.

What are the critical sample preparation considerations for ADIPOR1 detection?

ADIPOR1 exhibits significant temperature sensitivity during sample preparation, which is crucial for successful detection. Heating protein samples to temperatures of 60°C or greater can lead to a complete loss of detectable signal in western blot applications . Researchers should limit heating of protein samples to approximately 37°C when preparing for SDS-PAGE analysis . Even brief exposure (1 minute) to 95°C can strongly reduce the detected signal, a characteristic shared with other membrane proteins . This heat sensitivity must be factored into experimental design when working with ADIPOR1 antibodies to avoid false negative results and misinterpretation of expression levels.

What application methods are validated for ADIPOR1 antibodies?

Based on available research, ADIPOR1 antibodies have been successfully employed in multiple applications:

Researchers should perform validation tests for their specific application and tissue of interest, as antibody performance can vary significantly across experimental contexts .

How can researchers validate the specificity of ADIPOR1 antibodies?

Antibody validation is critical for ADIPOR1 research due to the prevalence of non-specific reagents. A comprehensive validation approach should include:

• Comparison of signal between wildtype and knockout samples (gold standard)

• CRISPR-Cas9 generated knockout cell lines as negative controls

• Verification of predicted molecular weight (43kDa for ADIPOR1)

• Testing on exogenous flag-tagged ADIPOR1 from plasmid transfections

• Analysis of tissue-specific expression patterns that align with established data

Research indicates that among fifteen commercially available antibodies tested in one study, only one could reliably detect endogenous ADIPOR1 protein, highlighting the importance of rigorous validation . Indirect ELISA can also be employed to determine antibody specificity and titer when working with synthetic peptide antigens .

How does protein expression of ADIPOR1 compare to its mRNA distribution?

A significant discrepancy exists between ADIPOR1 mRNA and protein expression patterns, which has important implications for research:

• mRNA expression: Previously reported to be near-ubiquitous with particularly high expression in skeletal muscle

• Protein expression: Dramatically enriched in the eye and brain with relatively low abundance in skeletal muscle, liver, pancreas, and adipose tissue

This discordance underscores the unreliability of relying solely on mRNA levels to infer protein expression. In a western blot analysis of different mouse tissues, strong ADIPOR1 protein signal was detected in eye and brain samples, while only faint bands were observed in other tissues . Further analysis confirmed that ADIPOR1 is indeed present in liver, muscle, and heart, but at significantly lower levels than suggested by mRNA data . Researchers should be aware of this discrepancy when designing experiments and interpreting results.

What approaches can be used to design custom antibodies against ADIPOR1?

Designing custom antibodies against ADIPOR1 requires careful bioinformatics analysis to ensure specificity and immunogenicity:

• Conduct sequence similarity analysis between ADIPOR1 and related proteins (especially ADIPOR2, which shares 66% amino acid sequence identity in mouse)

• Use computational tools to predict:

  • Physicochemical properties (e.g., using ExPASy)

  • Transmembrane structure (e.g., using TMHMM)

  • Antigen epitopes (e.g., using Antigenic Prediction)

  • Immunogenicity (e.g., using AntigenProfiler)

• Design a unique peptide sequence that ensures specificity (a 16-amino acid polypeptide has been successfully used)

• Verify peptide uniqueness through similarity searches in protein databases (SWISS-PROT, PDB, Prosite)

• Synthesize the selected peptide using solid-phase synthesis

• Use the synthetic peptide to immunize animals (e.g., rats) to generate polyclonal antibodies

This approach has successfully yielded antibodies with high titer and good specificity for ADIPOR1 detection .

What are the considerations for studying ADIPOR1 in retinal tissues?

ADIPOR1 plays a critical role in vision, making retinal tissue a key focus for research. When studying ADIPOR1 in retinal contexts:

• Expression pattern: In mouse retina, ADIPOR1 shows strongest signal in photoreceptor outer segments (OS) with weaker expression in the outer nuclear layer (ONL) and retinal pigment epithelium (RPE)

• Species differences: Human ADIPOR1 shows enrichment on the apical side of the RPE layer in paraffin-embedded sections, while protein is present in both neural retina and RPE as confirmed by western blotting

• Detection methods:

  • Immunohistochemistry works well on frozen cryosections for mouse retina

  • In situ hybridization (ISH) using RNAscope can identify mRNA distribution in human retina

  • Western blotting on separately dissected eye components (neural retina and posterior eye cup) can confirm protein expression

• Functional studies: Consider conditional knockout approaches targeting either RPE or photoreceptors specifically to understand cell-type specific roles

The essential role of ADIPOR1 in vision is evidenced by retinal degeneration in knockout models, with decreased expression of multiple retinal markers when ADIPOR1 is knocked out in adult animals .

How can researchers differentiate between ADIPOR1 and the closely related ADIPOR2?

Differentiating between ADIPOR1 and ADIPOR2 is essential for accurate characterization due to their high sequence similarity (66% amino acid identity in mouse) . Recommended approaches include:

• Antibody selection: Use antibodies raised against unique epitopes that do not share sequence homology between the two receptors

• Peptide competition assays: Perform pre-absorption tests with specific peptides to confirm antibody specificity

• Knockout controls: Include ADIPOR1-specific and ADIPOR2-specific knockout samples as controls

• Expression pattern analysis: Compare detected patterns with established distribution profiles (ADIPOR1 is highly enriched in eye and brain, whereas ADIPOR2 may show different tissue distribution)

• Molecular weight verification: Confirm that detected bands match the expected molecular weight (43kDa for ADIPOR1)

When designing experiments, researchers should also consider the functional overlap and potential compensatory mechanisms between these related receptors.

What methodological considerations are important when analyzing ADIPOR1 expression in disease models?

When investigating ADIPOR1 in disease contexts, several methodological considerations should be addressed:

• Appropriate controls: Include both positive and negative controls to account for potential expression changes (e.g., comparing wildtype and knockout tissues)

• Sample preparation consistency: Maintain consistent protein extraction and handling protocols, particularly regarding temperature sensitivity

• Multiple detection methods: Combine techniques (western blot, IHC, IF) to confirm expression patterns

• Disease-specific considerations:

  • For retinal degeneration models: Monitor electroretinograms (ERGs), photoreceptor loss, and docosahexaenoic acid (DHA) levels alongside ADIPOR1 expression

  • For metabolic studies: Be aware that protein levels may not correlate with previously reported mRNA patterns, particularly in tissues like liver and muscle

Research has shown no statistical difference in ADIPOR1 expression in muscle tissue between normal (1.80±0.06) and cholesterolemic mice (1.71±0.11) using western blot analysis, suggesting stable expression in some metabolic conditions .

What are common pitfalls in ADIPOR1 antibody-based experiments and how can they be avoided?

Several challenges commonly arise when working with ADIPOR1 antibodies:

• False negatives due to heat denaturation: Limit sample heating to 37°C during preparation

• Non-specific antibody binding: Thoroughly validate antibodies using knockout controls; studies have shown many commercial antibodies lack specificity

• Misinterpretation of expression patterns: Compare protein levels across multiple tissues rather than relying on mRNA data

• Inadequate sample preparation: For membrane proteins like ADIPOR1, optimized lysis buffers and extraction protocols are critical

• Cross-reactivity with ADIPOR2: Verify antibody specificity against both receptors, particularly in tissues where both are expressed

To overcome these challenges, researchers should implement rigorous controls, optimize sample preparation protocols specifically for membrane proteins, and validate all antibodies using both positive and negative controls.

What are the optimal dilution and incubation conditions for ADIPOR1 antibodies?

While optimal conditions will vary based on the specific antibody and application, general guidelines include:

• Western blot: Start with manufacturer's recommended dilution (typically 1:500-1:2000) and optimize based on signal-to-noise ratio

• IHC/IF: Begin with lower dilutions (1:100-1:500) for these applications which often require higher antibody concentrations

• Incubation temperatures: Consider 4°C overnight incubation to maximize specific binding while minimizing background

• Blocking conditions: Optimize blocking solutions (typically 5% BSA or 5% non-fat dry milk) to reduce non-specific binding

• Secondary antibody selection: Choose species-appropriate HRP or fluorophore-conjugated secondary antibodies

The search results emphasize that "the optimal dilutions should be determined by the end user" , highlighting the importance of protocol optimization for each specific research context.

How is ADIPOR1 research advancing our understanding of retinal diseases?

Recent findings have significantly shifted our understanding of ADIPOR1 function:

• Essential role in vision: ADIPOR1 knockout mice develop flecked retinas, accumulation of subretinal macrophages/microglia, and diminished electroretinograms (ERGs)

• Cell-type specific functions: ADIPOR1 in both photoreceptors and RPE cells is necessary for retinal health, as demonstrated by conditional knockout studies

• Docosahexaenoic acid (DHA) metabolism: ADIPOR1 knockout leads to severe preferential deficiency of DHA in the eye, suggesting a role in fatty acid metabolism essential for photoreceptor function

• Human disease relevance: Identification of human ADIPOR1 mutations that cause blindness highlights clinical significance

These findings suggest that ADIPOR1-targeted therapies could potentially address certain forms of retinal degeneration, shifting research focus from metabolic applications toward ophthalmological applications.

How can advanced imaging techniques enhance ADIPOR1 localization studies?

Advanced imaging approaches can provide deeper insights into ADIPOR1 subcellular localization and function:

• Super-resolution microscopy: Techniques like STORM or STED microscopy can reveal precise membrane localization beyond the diffraction limit of conventional microscopy

• Correlative light and electron microscopy (CLEM): Combining immunofluorescence with electron microscopy can provide ultrastructural context

• Live-cell imaging with fluorescently tagged ADIPOR1: Enables dynamic studies of receptor trafficking and interaction

• Multi-label confocal microscopy: Allows co-localization studies with other cellular markers to determine precise subcellular distribution

• Tissue clearing techniques: Methods like CLARITY can enable 3D visualization of ADIPOR1 distribution throughout intact tissues

Current research has established ADIPOR1's distribution in photoreceptor outer segments and RPE using conventional IHC , but advanced techniques could further elucidate its precise localization and potential interaction partners.